Banner

A Retrospective Study about the Serum Ferritin Level between Responder and Non-Responder Patients with Chronic HCV to Treatment by [PEG Interferon & Ribavirin Therapy] دراسة معدل الفريتين المصلي وعلاقته بالاستجابة لعلاج الفيوس الكبدي "سي" بعقار الانترفيرن والريبافيرين

Benha Medical Journal • 2013
Back
Publication Information
Authors Mustafa Soliman El-Kady1, Reda Mohammed El- Badawy1, Yasser Ahmed Shaheen1, Ibrahim Ahmed Awadin2 and Hatem Samir Abd El-raouf1
Keywords Chronic HCV, responders and non responders
Journal Benha Medical Journal
Publisher Banha Faculty of Medicine
Volume 30
Issue 1
Pages 507-517
publication.type International
Paper Link Not Available
Supplementary Materials Not Available
Abstract
The goal of treatment in patients with chronic hepatitis C virus (HCV) infection is to eradicate hepatitis C virus (HCV) RNA, the predictors for the patients that underwent interferon therapy is crucial. This is retrospective study carried jon 50 patients (40 males, 10 non pregnant females). The patients divided into 2 groups, (1) responder (29 males, 8 females), Mean age (50.5 ± 4.53 years old) and group (2) non responder (11 males, 2 females). Mean age (48.6±6.37 years old). The results of the investigations between responders and non responders was of no statistical significant, P value > 0.05 for all including iron indices (serum ferritin, serum iron and total iron binding capacity). There was statistical significant difference for T4, PCR viral load and INR, p value 0.05 and that was not statistically significant. Conclusion, patients with chronic HCV need more care for the prediction to the therapy to avoid the side effects as well as the economic cost. Werum ferritin level has no role to the prediction of therapy in this issue.